Patient stratification reveals the molecular basis of disease co-occurrences

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Epidemiological evidence shows that some diseases tend to co-occur; more exactly, certain groups of patients with a given disease are at a higher risk of developing a specific secondary condition. Here, we develop an approach to generate a disease network that uses the accumulating RNA-seq data on human diseases to significantly match an unprecedented proportion of known comorbidities, providing plausible biological models for such co-occurrences and effectively mirroring the underlying structure of complex disease relationships. Furthermore, 64% of the known disease pairs can be explained by analyzing groups of patients with similar expression profiles, highlighting the importance of patient stratification in the study of comorbidities. These results solidly support the existence of molecular mechanisms behind many of the known comorbidities, with most captured co-occurrences implicating the immune system. Additionally, we identified new and potentially underdiagnosed comorbidities, providing molecular insights that could inform targeted therapeutic strategies. We provide a functional and comprehensive resource to explore diseases, disease co-occurrences, and their underlying molecular processes at different resolution levels at http://disease-perception.bsc.es/rgenexcom/.

Cite

CITATION STYLE

APA

Urda-García, B., Sánchez-Valle, J., Lepore, R., & Valencia, A. (2025). Patient stratification reveals the molecular basis of disease co-occurrences. Proceedings of the National Academy of Sciences of the United States of America, 122(35). https://doi.org/10.1073/pnas.2421060122

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free